Read the Euroz Hartleys report (13 may 24) ......says it in there (& I've read elsewhere) - the sale of SOFDRA has a high profit margin BOT have said that themselves. The report mentioned above - also says that.....Sofdra is to sell for around $720 /script GROSS price (to match the competitor being Qbrexxa). It also says that will mean $540/script NET PRICING for sofdra.....to me that means - after ALL/majority of costs involved for SOFDRA....that's what each unit sale is worth to Botanix.
I've posted/mentioned this very recently on HC...simple really. Work your dream on that ($540/script.....maybe even $500/script if you like - WHICH IS AFTER ALL COSTS)......then let us know how it plays out in your calcs!
It is all written/announced previously - not makin this stuff up - I guess the sales & take up will tell. But we also know how that's been panning out so far for Japan don't we!
fuk...I'm just a little bit excited hey..
Ann: Final Sofdra Labelling Discussions with FDA, page-126
-
- There are more pages in this discussion • 157 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
-0.005(1.45%) |
Mkt cap ! $615.4M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 32.8¢ | $1.949M | 5.840M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2985 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 420471 | 4 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |